Why the study?
What are the clinical, virologic, and serologic effects of a live, attenuated VEE virus vaccine in healthy young men?
What are the clinical, virologic, and serologic effects of a live, attenuated VEE virus vaccine in healthy young men?
The live, attenuated VEE virus vaccine successfully induced serologic responses in all subjects, though it was associated with mild clinical reactions, transient viremia, leukopenia, and EKG changes.
Answers are grounded in this paper and cite their sources.
Vaccine induces universal seroconversion with transient viremia and EKG changes in volunteers; leaves open efficacy and safety in target populations.
SummaryForty young men were inoculated with live, attenuated VEE virus vaccine, and as evidenced by a significant increase in hemagglutination-inhibiting antibody titers, all were infected. However, viremia was demonstrated in only 13. The level of viremia was low, varied with time, and occurred between 60 hours and 12 days after vaccination. All subjects were evaluated closely from clinical, laboratory, virologic, and serologic standpoints. Some degree of reaction was seen in 37.5% of these persons, 10% of them having a 3+ reaction, of a possible 4+. Viremia was demonstrated in 32.5%. Transient electrocardiographic abnormalities were noted in 47.5%, and 40% had transient leukopenia. Eight men followed with daily electroencephalographic tracings demonstrated no significant change subsequent to vaccination. There was no consistent positive or negative correlation between any of these responses or combination of responses.
No takes yet. Share an insight, caveat, or question.
Alevizatos et al. (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: